Skip to main content
Premium Trial:

Request an Annual Quote

IncellDx Inks Chinese Collaboration, Distribution Agreements

NEW YORK – IncellDx and Kindstar Global announced today that they have signed master collaboration and exclusive distribution agreements for three of IncellDx's single-cell immuno-oncology and oncology diagnostic products for China. 

As part of the agreement, Kindstar will use Menlo Park, California-based IncellDx's tests — OncoTect iO Tumor Treatment Profile, OncoTect iO Bladder, and OncoBreast — in its laboratory system in China, including Hong Kong and Macao. The OncoTect iO Tumor Treatment Profile identifies PD-L1 expression as well as EGFR and ALK mutations; OncoTect io Bladder identifies bladder cancer and PD-L1 status from urine; and OncoBreast identifies ER, PR, HER2 protein, HER2 mRNA, and aneuploidy DNA simultaneously in breast samples. 

According to IncellDx, users can perform the assays in high throughput in less than three hours. 

"We are excited to broaden our presence in China with Kindstar, from whom we have seen tremendous growth over the years," IncellDx CEO and Founder Bruce Patterson said in a statement. "The scalability of our assays will make this opportunity a major growth driver for IncellDx in 2019 and beyond."

Financial details of the agreement were undisclosed.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.